The activation of MEK/ERK and Akt signaling pathways is required for PRKCI inducing tumor growth as tumor growth in PRKCI overexpressing cells were significantly suppressed by the MEK/ERK and Akt inhibitors (PD98059 and perifosine) (Figure 6C and 6D). Here, AKT1 is linked to neoplasm.